357 related articles for article (PubMed ID: 33966076)
1. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
[TBL] [Abstract][Full Text] [Related]
2. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Maziade PJ; Pereira P; Goldstein EJ
Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Auclair J; Frappier M; Millette M
Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
[TBL] [Abstract][Full Text] [Related]
5. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
6. Probiotics for primary prevention of
Fajnzylber J; Patterson W; Deshpande A
Curr Med Res Opin; 2023 Jun; 39(6):889-891. PubMed ID: 37078551
[TBL] [Abstract][Full Text] [Related]
7. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
[TBL] [Abstract][Full Text] [Related]
9. The potential of probiotics to prevent Clostridium difficile infection.
Allen SJ
Infect Dis Clin North Am; 2015 Mar; 29(1):135-44. PubMed ID: 25677707
[TBL] [Abstract][Full Text] [Related]
10. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.
Pattani R; Palda VA; Hwang SW; Shah PS
Open Med; 2013; 7(2):e56-67. PubMed ID: 24348885
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms and safety of probiotics against toxigenic
Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
Adv Exp Med Biol; 2024; 1435():101-116. PubMed ID: 38175473
[TBL] [Abstract][Full Text] [Related]
14. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE).
Allen SJ; Wareham K; Wang D; Bradley C; Sewell B; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D; Phillips CJ
Health Technol Assess; 2013 Dec; 17(57):1-140. PubMed ID: 24309198
[TBL] [Abstract][Full Text] [Related]
15. In-vitro determination of inhibitory effects of probiotic strains on Clostridioides difficile.
Yalçin GT; Tosun MN; Demirel Zorba NN
Anaerobe; 2023 Jun; 81():102737. PubMed ID: 37217116
[TBL] [Abstract][Full Text] [Related]
16. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
McFarland LV; Johnson SB; Evans CT
Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Bio-K+ for the prevention of
Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.
Spinler JK; Auchtung J; Brown A; Boonma P; Oezguen N; Ross CL; Luna RA; Runge J; Versalovic J; Peniche A; Dann SM; Britton RA; Haag A; Savidge TC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760934
[TBL] [Abstract][Full Text] [Related]
19. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
McFarland LV; Ship N; Auclair J; Millette M
J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
